CAPTRUST Financial Advisors
CTOR icon

CAPTRUST Financial Advisors’s Citius Oncology CTOR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.2K Buy
+21,000
New +$16.4K ﹤0.01% 3324

Other funds holding CTOR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

CAPTRUST Financial Advisors's CTOR Position: Q3 2026 in Review

CAPTRUST Financial Advisors opened a new position in Citius Oncology (CTOR) in Q3 2026: 21,000 shares worth $21.2K. The stake represents ﹤0.01% of the portfolio and ranks #3324 among its holdings.

13 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.

  • CAPTRUST Financial Advisors held 21,000 shares of Citius Oncology worth $21.2K as of Q3 2026.
  • Citius Oncology was a new CAPTRUST Financial Advisors position in Q3 2026.
  • Citius Oncology made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3324 holding.
  • 13 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.